Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported Licence

Photoswitchable probe with distinctive characteristics for selective fluorescence imaging and long-term tracing

Zhenzhen Tu, Qian Zhang, Xiuxia Xu, Lianhui Wang, Yan Qian* and Wei Huang*
Key Laboratory for Organic Electronics & Information Displays, Institute of Advanced Materials (IAM), Nanjing University of Posts & Telecommunications, 9 Wenyuan Road, Nanjing, 210023, China. E-mail: iamyqian@njupt.edu.cn; iamwhuang@njupt.edu.cn; Fax: +86 25 8586 6999; Tel: +86 25 8586 6008

Received 7th December 2018 , Accepted 28th January 2019

First published on 7th February 2019


Abstract

A photo-switchable and high-contrast bio-imaging indicator 4,4′-(1E,1′E)-(4,4′-(cyclopentene-1,2-diyl)bis(5-methylthiophene-4,2-diyl))bis(methan-1-yl-1-ylidene)bis(azan-1-yl-1-ylidene)bis(2-(benzo[d]thiazol-2-yl)phenol) (BMBT) has been demonstrated, by integrating photochromophore with excited-state intramolecular proton transfer (ESIPT) moiety. The ability of reversible emission switching enables arbitrarily selective labeling or concealing of cells simply by controlling light irradiation. Besides, when the emission was switched on, BMBT is demonstrated to exhibit unique characteristics of aggregation induced emission (AIE), providing a high on–off ratio for favorable bio-imaging. Thus, the non-labeling and easily-controlled selective imaging, as well as good biocompatibility indicates BMBT to be a favorable cell probe with great potentials for functional bio-imaging fluorophore.


Although there are many conventional fluorescent probes used for fluorescent imaging in the past few years,1–5 such as rhodamine,6 cyanine dye,7 quantum dots,8,9 and lanthanide probes,10 these fluorescent probes can only respond irreversibly to one event.11,12 In comparison, photochromophores,13 which can reversibly response with UV and visible light,14 are more valuable fluorescent probes for regional optical marking of interested cells.15,16 Because of their favourable characteristics, such as excellent thermal stability, good fatigue resistance and fast response time, diarylethenes derivatives have drawn wide spread concern of researchers.17–20 Furthermore, the special optical properties of diarylethenes enable them to be suitable for long time and real time monitoring in bioimaging.

The significance of targeted imaging of fluorescence probe for bio-samples in vitro or in vivo is well-known for their high sensitivity, non-invasiveness, real-time detection and especially selectivity.21–24 However, the synthesis of these targeting materials is usually complicated. Moreover, for the same type of cells, no selectivity is demonstrated by these complex targeting agents.21–24 Therefore, easy-prepared and easy-controlled non-labeling fluorescence imaging agents have always been pursued by both the industry and scientific communities. Among the above-mentioned photochromophores, diarylethenes are expected to be promising photochromic imaging candidates due to their favorable characteristics described in preceding paragraph. Prospectively, they can be used for selective long-term tracing if the photostability can be ensured.

In our previous work, a series of AIE-active excited-state intramolecular proton transfer (ESIPT) complexes have been demonstrated to be good bio-imaging candidate with many advantages such as simple preparation, good biocompatibility, high quantum yields, fast cell staining as well as long-term anti-photobleaching.25–27 Sometimes, ESIPT compounds exhibit dual emission, originated from keto and enol state, respectively. This caused extremely fast four-level photophysical cycle (E–E*–K*–K–E), mediated by intramolecular H-bonds immediately after photoexcitation, enables two emissions.28,29 Herein, we have demonstrated a new type of multifunctional bio-imaging materials based on facile synthesis design concept, by introducing a photochromic diarylethene moiety to enable regional emission turn-on, and introducing an ESIPT moiety to allow good photo stability for long-term tracing. To the best of our knowledge, this is the first example with integrating abilities of non-labeling selectively long-term regional tracing.

The new diarylethene derivative (BMBT, see the molecular structure in Scheme 1) has been synthesized (Fig. S1) via condensation reaction of 5-amino-2-(benzo[d]thiazol-2-yl)phenol with 4,4-(cyclopentene-1,2-yl)-bis(5-methyl-thiophene-2-formaldehyde), according to a previous reported procedure.30,31 The molecular structures and purities were confirmed by 1H NMR spectroscopy and mass spectroscopy (Fig. S6 and S7, see the synthesis details and full molecular characterizations in the ESI).


image file: c8ra10057h-s1.tif
Scheme 1 Structure and photochromic process of BMBT.

The photoirradiation-induced changes in absorption and fluorescence spectra at room temperature are investigated in THF/DMEM mixture (1.0 × 10−5 mol L−1). The open-ring isomer mainly exhibits two absorption peaked at 304 and 380 nm, respectively (Fig. S2). This is ascribed to the internal charge transfer and π–π transition of 2-(2′-hydroxy-phenyl)benzothiazole (HBT),10,30 coupled with the CT inside the HBT unit from the hydroxyphenyl ring to the benzothiazole ring (Scheme 1). BMBT exhibits two emissions; one blue emission peak around 458 nm and a red emission peak around 600 nm, corresponding to the enol and keto emission, respectively (Fig. 1). Upon irradiation with ultraviolet light at 365 nm, the absorption band at longer wavelength region centered at 595 nm increased obviously with irradiation time (Fig. S2). This is caused by the formation of the closed-ring isomer (see the photochromic reaction in Scheme 1). Correspondingly, due to spectroscopic overlap between this longer-wavelength absorbance with the red emission ranged from 560–700 nm, the relative intensity of the red emission substantially decreases with the UV irradiation (Fig. 1), because of efficient energy transfer. Upon further visible light (λ = 520 nm) irradiation, the closed-ring isomer transfers back to the initial open-ring isomer, and thus the longer-wavelength absorption decreases and the red emission restores. This indicates good reversibility of the photochromic reaction.


image file: c8ra10057h-f1.tif
Fig. 1 Fluorescence emission changes of BMBT in THF/DMEM (1[thin space (1/6-em)]:[thin space (1/6-em)]200, vol[thin space (1/6-em)]:[thin space (1/6-em)]vol) mixture upon irradiation with 365 nm light (λex = 385 nm) and visible light (λex = 520 nm).

Excitingly, BMBT exhibit prominent characteristics of Aggregation-Induced Emission (AIE).31–33 The fluorescence intensity of BMBT in THF solution was relatively weak, while the powder or nanoparticles of the material dispersed in DMEM buffer exhibited a significantly enhanced emission (Fig. 2). When the DMEM buffer fraction was increased gradually from 0% to 20%, the fluorescence intensity only slightly enhanced. When the DMEM fraction was further increased to 40%, the emission exhibits a significant enhancement. The total intensity at the blue enol emission increased more than 10 times at 100% DMEM fraction as compared with that in THF solution. This AIE property enables high signal-to-noise ratios for favorable bioimaging (Fig. S3).


image file: c8ra10057h-f2.tif
Fig. 2 Fluorescence spectra of 1 × 10−5 M BMBT in the THF/DMEM mixture at different water fractions (λex = 385 nm).

Based on the good reversibility of light response and AIE characteristics, the practical application of the BMBT as bioprobe was further investigated. The biological imaging of BMBT was observed by using confocal laser scanning microscopy (CLSM). Blue luminescence in the cytoplasm of HeLa cells was observed after incubation with a THF/DMEM (1[thin space (1/6-em)]:[thin space (1/6-em)]200, vol[thin space (1/6-em)]:[thin space (1/6-em)]vol) solution of BMBT (20 μM) for 30 min at 37 °C (Fig. 2 inset). The overlay of luminescent images and bright-field images confirmed that BMBT was located mainly in the cytoplasm of cells rather than the membrane and nucleus (Fig. S3). Intense intracellular luminescence with a high signal-to-noise ratio (I1/I2 > 7) was detected between the cytoplasm (regions 3 and 1) and nucleus (region 2), also implying weak even few nuclear uptake of BMBT (Fig. S4). Besides, BMBT has a low cytotoxicity with the cellular viabilities estimated to be greater than 85% after 24 h incubation with the highest cultural concentration of 50 μM BMBT (Fig. S5).

The luminescence switching of BMBT can also be achieved while alternating UV and visible light illumination in fixed HeLa cells. Cells (shown in red circle, Fig. 3a) were irradiated with 488 nm light (0.5 mW) for 3 min, the blue fluorescence of the irradiated cells was lamped off while the surrounding cells remained almost unchanged. Such fluorescence quenching is likely ascribed to the intramolecular fluorescence resonance energy transfer of BMBT, due to the intensified short-wavelength absorption band (270–450 nm) of the closed-open form of BMBT with the blue emission band (420–560 nm).34 Upon irradiation with 405 nm light (1.25 mW) the fluorescence of all the selected cell was rapidly recovered within 1 min, caused by decrease of the relative intensity of the 270–450 nm absorption. The fluorescence can be repeatedly erased and recovered many rounds without significant fluorescence quenching, which was hardly achieved by conventional fluorophores (Fig. 3b).35,36


image file: c8ra10057h-f3.tif
Fig. 3 (a) CLSM image (above) and the overlay image (bottom) of fixed HeLa cells incubated with 20 μM BMBT for 30 min at 37 °C (1) and (5) in original state; (2) and (6) irradiated by 488 nm light (0.5 mW) for a single cell; (3) and (7) all cells, and; (4) and (8) recovered by 405 nm light (1.25 mW). (b) Fluorescence switching of fixed HeLa cells by alternating UV (405 nm, 1.25 mW, 10 s/time) and visible (488 nm, 0.5 mW, 3 min/time) light illumination (λex = 405 nm).

This characteristic of selectively opto-marking or de-marking of cells may be used for non-invasive and dynamic tracing of the interested objects in vitro. That is, BMBT can arbitrarily opto-label or de-label interested cells without affecting cell proliferation. As shown in Fig. 4, the cell marked in the red circle was treated with visible light illumination (488 nm, 0.5 mW, 3 min), and its fluorescence was effectively quenched. Cells division of the remaining “bright” cells was observed under the microscope field of vision for a long-term tracing with time up to 36 h. Multiple new cells were produced, as indicated by upper white arrow. Even, as indicated by bottom white arrow, the tacked cells were observed to be doubled. The high brightness of the fluorescence in the proliferated cells indicated the good photo stability of BMBT. This indicated that BMBT can be used as a cell marker for arbitrarily selective erasing the fluorescence of the designated cell. It can also be used for selective lighting their emission by making them as the remaining bright cells after selective photo-erasing or selective photo-recovering after full erasing. This long-term tracking with non-labeling and selective optically marking or de-marking is seldom reported by other photochromophore-based bioimaging agents.37 Herein, the excellent anti-photo bleaching characteristic in the long-term tracing is attributed to high photo stability of the HBT moiety.26,27


image file: c8ra10057h-f4.tif
Fig. 4 Cells was treated with visible (488 nm, 0.5 mW, 3 min) light illumination for erasing the fluorescence. The remaining bright cells were incubated for another 36 hours, which were observed to be amplified normally (λex = 405 nm).

Conclusions

To summarize, a photochromic diarylethene based on 2-(2′-hydroxyphenyl)benzothiazole called BMBT was designed and investigated to be an luminescence probe, which has an outstanding switchable photochromic characteristic for arbitrarily optically labeling or delabeling interested cells without affecting cell proliferation. As far as we know, this is the first bioimaging fluorophore that simultaneously exhibit unique characteristics of aggregation induced emission (AIE) and non-labeling selectively imaging for biological detection in vitro. Further investigation for the in vivo application is undergoing.

Conflicts of interest

There are no conflicts to declare.

Acknowledgements

This study was funded by the National Natural Science Foundation of China (61605085, 21373114, 21573111, 21603106), National Key Basic Research Program of China (973) (2012CB933301), Project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, PAPD (YX030002), Program for Changjiang Scholars and Innovative Research Team in University (IRT1148), Research Foundation from Nanjing University of Posts and Telecommunications (XK0300915081), Qing Lan Project of Jiangsu Province and NUPT 1311 Project, Jiangsu Key Laboratory for Biosensors, Synergetic Innovation Center for Organic Electronics and Information Displays, Jiangsu National Synergetic Innovation Center for Advanced Materials (SICAM).

Notes and references

  1. Z. Chen, K. Y. Zhang, X. Tong, Y. Liu, C. Hu, S. Liu, Q. Yu, Q. Zhao and W. Huang, Adv. Funct. Mater., 2016, 26, 4386–4396 CrossRef CAS.
  2. Y. Zhang, S. Li and Z. Zhao, Anal. Chem., 2016, 88, 12380–12385 CrossRef CAS PubMed.
  3. Y. Zhang, T. T. Shen, A. M. Kirillov, W. S. Liu and Y. Tang, Chem. Commun., 2016, 52, 7939–7942 RSC.
  4. J. Huang, L. Ying, X. Yang, Y. Yang, K. Quan, H. Wang, N. Xie, M. Ou, Q. Zhou and K. Wang, Anal. Chem., 2015, 87, 8724–8731 CrossRef CAS PubMed.
  5. J. Shangguan, D. He, X. He, K. Wang, F. Xu, J. Liu, J. Tang, X. Yang and J. Huang, Anal. Chem., 2016, 88, 7837–7843 CrossRef CAS PubMed.
  6. A. Sahana, A. Banerjee, S. Lohar, B. Sarkar, S. K. Mukhopadhyay and D. Das, Inorg. Chem., 2013, 52, 3627–3633 CrossRef CAS PubMed.
  7. J. R. Carreon, K. M. Stewart, K. P. Mahon, S. Shin and S. O. Kelley, Bioorg. Med. Chem. Lett., 2007, 17, 5182–5185 CrossRef CAS PubMed.
  8. Y. C. Lu, J. Chen, A. J. Wang, N. Bao, J. J. Feng, W. P. Wang and L. X. Shao, J. Mater. Chem., 2015, 3, 73–78 CAS.
  9. X. D. Zhang, H. X. Wang, H. Wang, Q. Zhang, J. F. Xie, Y. P. Tian, J. Wang and Y. Xie, Adv. Mater., 2014, 26, 4438–4443 CrossRef CAS PubMed.
  10. J. C. G. Bunzli, Lanthanide Luminescence for Biomedical Analyses and Imaging, Chem. Rev., 2010, 110, 2729–2755 CrossRef PubMed.
  11. H. Takakusa, K. Kikuchi, Y. Urano, S. Sakamoto, K. Yamaguchi and T. Nagano, J. Am. Chem. Soc., 2002, 124, 1653–1657 CrossRef CAS PubMed.
  12. M. Zhang, M. X. Yu, F. Y. Li, M. W. Zhu, M. Y. Li, Y. H. Gao, L. Li, Z. Q. Liu, J. P. Zhang and D. Q. Zhang, J. Am. Chem. Soc., 2007, 129, 10322–10323 CrossRef CAS PubMed.
  13. W. L. Li, C. H. Jiao, X. Li, Y. S. Xie, K. Nakatani, H. Tian and W. H. Zhu, Angew. Chem., Int. Ed., 2014, 53, 4603–4607 CrossRef CAS PubMed.
  14. M. Q. Zhu, L. Y. Zhu, J. J. Han, W. W. Wu, J. K. Hurst and A. D. Q. Li, J. Am. Chem. Soc., 2006, 128(13), 4303–4309 CrossRef CAS PubMed.
  15. L. Y. Zhu, W. W. Wu, M. Q. Zhu, J. J. Han, J. K. Hurst and A. D. Q. Li, J. Am. Chem. Soc., 2007, 129, 3524–3526 CrossRef CAS PubMed.
  16. J. Wiedenmann, S. Ivanchenko, F. Oswald, F. Schmitt, C. Rocker, A. Salih, K. D. Spindler, G. U. Nienhaus and F. P. Eos, Proc. Natl. Acad. Sci. U. S. A., 2004, 101, 15905–15910 CrossRef CAS PubMed.
  17. H. Tian, B. Qin, R. X. Yao, X. L. Zhao and S. J. Yang, Adv. Mater., 2003, 15, 2104–2107 CrossRef CAS.
  18. M. Irie, T. Fulcaminato, K. Matsuda and S. Kobatake, Chem. Rev., 2014, 114, 12174–12277 CrossRef CAS PubMed.
  19. C. Yun, J. You, J. Kim, J. Huh and E. Kim, J. Photochem. Photobiol., C, 2009, 10, 111–129 CrossRef CAS.
  20. G. L. Lv, B. P. Cui, H. C. Lan, Y. Wen, A. Y. Sun and T. Yi, Chem. Commun., 2015, 51, 125–128 RSC.
  21. W. Wang, Y. Huang, S. Wang, Y. Zhou, W. Huang, Y. Feng, W. Zhang, W. Yu, Q. Zhou, M. Chen and M. Fang, Spectrochim. Acta, Part A, 2017, 187, 110–118 CrossRef CAS PubMed.
  22. W. Xu, P. Ma, Q. Diao, L. Xu, X. Liu, Y. Sun, X. Wang and D. Song, Sens. Actuators, B, 2017, 252, 86–94 CrossRef CAS.
  23. W. Xu, G. Han, P. Ma, Q. Diao, L. Xu, X. Liu, Y. Sun, X. Wang and D. Song, Sens. Actuators, B, 2017, 251, 366–373 CrossRef CAS.
  24. S. Du, D. Wang, J. S. Lee, B. Peng, J. Ge and S. Q. Yao, Chem. Commun., 2017, 53, 8443–8446 RSC.
  25. Y. Qian, M. M. Cai, L. H. Xie, G. Q. Yang, S.-K. Wu and W. Huang, ChemPhysChem, 2011, 12, 397–404 CrossRef CAS PubMed.
  26. Z. Tu, M. Liu, Y. Qian, G. Yang, M. Cai, L. Wang and W. Huang, RSC Adv., 2015, 5, 7789–7793 RSC.
  27. Z. Tu, Q. Zhang, M. Liu, Y. Qian, L. Wang and W. Huang, J. Mater. Sci., 2016, 51, 2972–2979 CrossRef CAS.
  28. Y. Qian, S. Li, G. Zhang, Q. Wang, S. Wang, H. Xu, C. Li, Y. Li and G. Yang, J. Phys. Chem. B, 2007, 111, 5861–5868 CrossRef CAS PubMed.
  29. M. Cai, Z. Gao, X. Zhou, X. Wang, S. Chen, Y. Zhao, Y. Qian, N. Shi, B. Mi, L. Xie and W. Huang, Phys. Chem. Chem. Phys., 2012, 14, 5289–5296 RSC.
  30. Y. Cheng, C. Sun, X. Ou, B. Liu, X. Lou and F. Xia, Chem. Sci., 2017, 8, 4571–4578 RSC.
  31. Q. Y. Fang, J. W. Li, S. Y. Li, R. H. Duan, S. Q. Wang, Y. P. Yi, X. D. Guo, Y. Qian, W. Huang and G. Q. Yang, Chem. Commun., 2017, 53, 5702–5705 RSC.
  32. H. Y. Li, Z. G. Chi, B. J. Xu, X. Q. Zhang, Z. Y. Yang, X. F. Li, S. W. Liu, Y. Zhang and J. R. Xu, J. Mater. Chem., 2010, 20, 6103–6110 RSC.
  33. S. Dong, Z. Li and J. Qin, J. Phys. Chem. B, 2009, 113, 434–441 CrossRef CAS PubMed.
  34. G. Y. Jiang, S. Wang, W. F. Yuan, L. Jiang, Y. L. Song, H. Tian and D. B. Zhu, Chem. Mater., 2006, 18, 235–237 CrossRef CAS.
  35. M. Heilemann, S. van de Linde, M. Schuttpelz, R. Kasper, B. Seefeldt, A. Mukherjee, P. Tinnefeld and M. Sauer, Angew. Chem., Int. Ed., 2008, 47, 6172–6176 CrossRef CAS PubMed.
  36. A. Negre-Salvayre, N. Auge, C. Duval, F. Robbesyn, J. C. Thiers, D. Nazzal, H. Benoist and R. Salvayre, Methods Enzymol., 2002, 352, 62–71 CAS.
  37. Y. Zou, T. Yi, S. Xiao, F. Li, C. Li, X. Gao, J. Wu, M. Yu and C. Huang, J. Am. Chem. Soc., 2008, 130, 15750–15751 CrossRef CAS PubMed.

Footnote

Electronic supplementary information (ESI) available: Procedures and results of additional experiments See DOI: 10.1039/c8ra10057h

This journal is © The Royal Society of Chemistry 2019
Click here to see how this site uses Cookies. View our privacy policy here.